继续上攻！医疗ETF（512170）飙涨5%！AI医疗大爆发，迪安诊断20CM涨停！CXO同步冲高，药明康德涨超5%

市场资讯02-14

14日午后，医疗板块继续上攻，A股顶流医疗ETF（512170）飙涨5.11%，成交额超10.6亿元，已是昨日全天成交额的2倍之多。　　成份股方面，AI医疗、CXO联袂拉涨！迪安诊断20CM涨停，三诺生物、卫宁健康、华大智造等6股涨超10%，达安基因、美年健康、金域医学等3股涨停，CXO龙头股药明康德、康龙化成大涨超5%，泰格医药涨超7%。　　资金面上，主力资金大举涌入医药医疗！截至发稿...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2511635073?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-14 13:41","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2511635073","market":"sh","top_or_hot":-1,"title":"继续上攻！医疗ETF（512170）飙涨5%！AI医疗大爆发，迪安诊断20CM涨停！CXO同步冲高，药明康德涨超5%","media":"市场资讯","content":"<div>\n<p>14日午后，医疗板块继续上攻，A股顶流医疗ETF（512170）飙涨5.11%，成交额超10.6亿元，已是昨日全天成交额的2倍之多。\n\n　　成份股方面，AI医疗、CXO联袂拉涨！迪安诊断20CM涨停，三诺生物、卫宁健康、华大智造等6股涨超10%，达安基因、美年健康、金域医学等3股涨停，CXO龙头股药明康德、康龙化成大涨超5%，泰格医药涨超7%。\n\n　　资金面上，主力资金大举涌入医药医疗！截至发稿...</p>\n\n<a href=\"https://finance.sina.com.cn/money/fund/etf/2025-02-14/doc-inekmpzk6881572.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>继续上攻！医疗ETF（512170）飙涨5%！AI医疗大爆发，迪安诊断20CM涨停！CXO同步冲高，药明康德涨超5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n继续上攻！医疗ETF（512170）飙涨5%！AI医疗大爆发，迪安诊断20CM涨停！CXO同步冲高，药明康德涨超5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-14 13:41 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/money/fund/etf/2025-02-14/doc-inekmpzk6881572.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>14日午后，医疗板块继续上攻，A股顶流医疗ETF（512170）飙涨5.11%，成交额超10.6亿元，已是昨日全天成交额的2倍之多。\n\n　　成份股方面，AI医疗、CXO联袂拉涨！迪安诊断20CM涨停，三诺生物、卫宁健康、华大智造等6股涨超10%，达安基因、美年健康、金域医学等3股涨停，CXO龙头股药明康德、康龙化成大涨超5%，泰格医药涨超7%。\n\n　　资金面上，主力资金大举涌入医药医疗！截至发稿...</p>\n\n<a href=\"https://finance.sina.com.cn/money/fund/etf/2025-02-14/doc-inekmpzk6881572.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0146","symbol_name":"智慧医疗","start_time":0,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-02-14/doc-inekmpzk6881572.shtml","article_id":"2511635073","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2511635073","pubTimestamp":1739511660,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"14日午后，医疗板块继续上攻，A股顶流医疗ETF飙涨5.11%，成交额超10.6亿元，已是昨日全天成交额的2倍之多。　　成份股方面，AI医疗、CXO联袂拉涨！迪安诊断20CM涨停，三诺生物、卫宁健康、华大智造等6股涨超10%，达安基因、美年健康、金域医学等3股涨停，CXO龙头股药明康德、康龙化成大涨超5%，泰格医药涨超7%。风险提示：医疗ETF及其联接基金被动跟踪中证医疗指数，该指数基日为2004.12.31，发布于2014.10.31。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159828":"医疗ETF","159891":"医疗","300244":"迪安诊断","512170":"医疗ETF","603259":"药明康德","BK0146":"智慧医疗","02359":"药明康德","BK0186":"小盘成长","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","BK1141":"生命科学工具和服务","BK0197":"中小创蓝筹","BK1576":"医药外包概念","BK0236":"卫生","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0052750758.USD":"富兰克林中国基金A Acc","BK0042":"基因检测","BK0114":"健康中国","CXO":"康休","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK0028":"国家队","BK1583":"高瓴概念","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU1997245177.USD":"安联神洲A股基金","BK0070":"员工持股","BK0216":"研究试验","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD"},"translate_title":"Continue to attack! Medical ETF (512170) soared 5%! AI medical outbreak, Dean diagnoses 20CM daily limit! CXO surged simultaneously, WuXi AppTec rose more than 5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159828":0.6,"159891":0.6,"300244":0.6,"512170":0.6,"603259":0.6,"02359":0.6,"CXO":0.6},"content_text":"14日午后，医疗板块继续上攻，A股顶流医疗ETF（512170）飙涨5.11%，成交额超10.6亿元，已是昨日全天成交额的2倍之多。\n\n　　成份股方面，AI医疗、CXO联袂拉涨！迪安诊断20CM涨停，三诺生物、卫宁健康、华大智造等6股涨超10%，达安基因、美年健康、金域医学等3股涨停，CXO龙头股药明康德、康龙化成大涨超5%，泰格医药涨超7%。\n\n　　资金面上，主力资金大举涌入医药医疗！截至发稿医药生物行业主力净流入近92亿元，在31个申万一级行业中高居第二！个股方面，药明康德、美年健康、迈瑞医疗净流入额跻身前五。\n\n　　消息面上，华为数据储存公众号发布信息称，将发布基于华为DCS AI解决方案打造的瑞金病理模型。据介绍，该模型将于2月18日举办的“2025医疗人工智能与精准诊疗发展论坛”上发布。\n　　中信证券研报表示，医疗垂类大模型凭借更强的理解、生成、多模态能力，从提质、增效两条路径拓展了更复杂情境下的AI+医疗市场空间。\n　　前瞻产业研究院预计，中国AI医疗行业市场规模将会以每年超过25%的增速保持增长，2028年市场规模将接近300亿元。\n　　就医疗板块整体观点，国联证券认为，过去几年医药医疗板块回撤较多，积累了大量左侧低估值资产，如CXO、消费医疗等，建议关注左侧资产的需求韧性和估值修复。\n　　DeepSeek掀起AI热潮，AI+有望为医疗注入新的生命力！投资角度，配置工具可以考虑关注兼具规模和流动性优势的医疗ETF（512170），该ETF被动跟踪中证医疗指数，一半仓位押注医疗器械龙头，另一半仓位兼顾“医疗服务+医美+医疗IT”等领域龙头，覆盖7只CXO龙头股。\n　　需要特别提示的是，医药医疗板块调整时间较长，波动较大，短线反弹不预示未来表现。关注医药医疗投资机会的投资者务必根据自身的资金状况和风险承受能力理性投资，高度注意仓位和风险管理。\n\n　　图片来源于iFinD、沪深交易所。风险提示：医疗ETF（512170）及其联接基金被动跟踪中证医疗指数，该指数基日为2004.12.31，发布于2014.10.31。文中指数成份股仅作展示，个股描述不作为任何形式的投资建议，也不代表管理人旗下任何基金的持仓信息和交易动向。中证医疗指数2020年至2024年的分年度业绩分别为79.67%、-14.71%、-25.1%、-24.25%、-17.16%，标的指数成份股构成根据该指数编制规则适时调整，其回测历史业绩不预示指数未来表现。基金管理人评估的该基金及其联接基金的风险等级分别为R3-中风险、R4-中高风险，分别适宜平衡型（C3）、积极型（C4）及以上投资者，适当性匹配意见请以销售机构为准。任何在本文出现的信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，投资人须对任何自主决定的投资行为负责。另，本文中的任何观点、分析及预测不构成对阅读者任何形式的投资建议，亦不对因使用本文内容所引发的直接或间接损失负任何责任。基金投资有风险，基金的过往业绩并不代表其未来表现，基金管理人管理的其他基金的业绩并不构成基金业绩表现的保证，基金投资须谨慎。\n\nMACD金叉信号形成，这些股涨势不错！\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：杨赐","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2511635073"}